Rheumatoid Arthritis eJournal Club
   

Rheumatoid Arthritis and Imaging

Print this Content
 
Release Date:  January 15, 2009 Renewal Date:  January 19, 2010 Expiration Date:  June 19, 2010

Technical Requirements
(will appear in new window)
 
Estimated Time of Completion 1 hour
Description / Overview

The purpose of this activity is to review how imaging techniques might assist in the evaluation of a patient with rheumatoid arthritis (RA) and how these techniques correlate to clinical response and affect RA treatment decisions.
Objectives At the conclusion of this activity, the participant will be able to:
  1. Identify and explain imaging techniques used for management of a patient with RA.
  2. Review data that correlates results from imaging to clinical response in patients with RA.
  3. Discuss treatment options for a patient with RA, taking into account results from imaging studies.
Target Audience This activity is directed to rheumatologists and primary care physicians who treat patients with RA.
Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Activity Director Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Vice Chairman
Department of Rheumatic & Immunologic Diseases
R.J. Fasenmyer Chair of Clinical Immunology
Cleveland Clinic
Cleveland, Ohio
Author / Faculty Jonathan Kay, MD
Associate Clinical Professor of Medicine
Harvard Medical School
Director of Clinical Trials
Rheumatology Unit
Massachusetts General Hospital
Boston, Massachusetts

Faculty Disclosure In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty has indicated that he may have a relationship which, in the context of his presentation, could be perceived as a potential conflict of interest:

Leonard Calabrese, DO
  Consulting: Abbott Laboratories;
Elan Pharmaceuticals, Inc.;
Genentech, Inc.; Roche Laboratories, Inc.
 
  Teaching and Speaking: Genentech, Inc.

 

Jonathan Kay, MD
  Consulting Amgen Inc.; Centocor, Inc.: Genentech, Inc.; Roche Laboratories, Inc.; UCB; Wyeth Pharmaceuticals
     
  Independent Contractor Amgen Inc.; Centocor, Inc.; Genentech, Inc.; Novartis Pharmaceuticals Corp; Roche Laboratories, Inc.
     
  Membership on advisory committee or review panels Centocor, Inc.

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of this activity from:

Bristol – Myers Squibb Company, Genentech/Biogen Idec

Wyeth Pharmaceuticals

This CME activity was produced by The Cleveland Clinic Foundation
Center for Continuing Education and DIME.

CME Disclaimer